pharma · Androgenetic Alopecia · Acute Myocardial Infarction
Dong Wang
Dong Wang clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CN
- Programs
- 8
- Drugs
- 13
- Patents
- 0
Dong Wang projects
8 ClinicalTrials.gov programs sponsored by Dong Wang.
Dong Wang has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Telmisartan/Amlodipine
Dong Wang
Hypertension With Hyperlipidemia
1 trial -
evogliptin
Dong Wang
Type 2 Diabetes Mellitus
1 trial -
DA-4001C
Dong Wang
Androgenetic Alopecia
1 trial -
Aricept 5mg Tablet
Dong Wang
Healthy
1 trial -
DA-5210 10/500mg
Dong Wang
Healthy
1 trial -
De-escalation strategy
Dong Wang
Acute Myocardial Infarction
1 trial -
Risedronate Sodium 35 MG [Actonel]
Dong Wang
Postmenopausal Osteoporosis
1 trial -
rivastigmine patch
Dong Wang
Alzheimer's Disease
1 trial
Frequently asked questions
How many clinical projects does Dong Wang have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.